Drug Database
Back to search

Switzerland· 69128002

AQUIPTA 60 mg, Tabletten

A atogepant product, registered in Switzerland by AbbVie AG and dispensed under Swissmedic category B. The same ATC class is registered in 16 of our 19 countries.

Cat B (Swissmedic)ATC N02CD07

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedAQUIPTA 60 mg, TablettenATCN02CD07REGISTER NO.69128002PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about AQUIPTAAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Atogepant is registered in 16 of 19 countries.

Countries holding a registration under ATC N02CD07 (atogepant), each read from that country’s own register.

  • This record: Switzerland
  • 11 of them publish a price we can compare per daily dose
Search atogepant products by name

Atogepant · ATC N02CD07

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of atogepant costs, country by country.

Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.

  • Switzerland: $95.15 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Atogepant · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • IT Italy$96.51
  • CH Switzerland$95.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Manufacturer
AbbVie AG
Country
Switzerland (CH)
ATC code
N02CD07
ATC class
Atogepant
Defined daily dose
60 mg, O
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under N02CD07

Atogepant, as other registers publish it.

All atogepant products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be261ff1-d7b0-4b91-933e-35dd0ef03ed3
GET /v1/drugs/be261ff1-d7b0-4b91-933e-35dd0ef03ed3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
API referenceMCP serverPlans

See everything about atogepant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console